Shots:
Raviv Pryluk, CEO and Co-Founder of PhaseV, in a stimulating conversation with PharmaShots, sheds light on the company’s recent partnership with 9xchange Biopharma
The partnership aims to bring Phase V’s proprietary machine learning (ML) technology to ecosystem members, enabling them, to retrospectively analyze and optimally design and execute advanced clinical studies
Raviv highlights the…
Shots:
In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and Healthcare
In 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…
Shots:
The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industry
In February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative Colitis
PharmaShots has compiled a list of a total…
In an era prioritizing precision and profound insight, the advancement of imaging solutions has been truly remarkable. Starting from the rudimentary origins of X-ray technology to the intricate multi-modal imaging systems of today, the journey of visualizing the invisible has been characterized by unwavering innovation.
Nonetheless, as the complexity of our inquiries escalates, the sophistication…
Shots:
Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio
Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program
Betty believes that through innovation and partnership, they can tap into the full…
Shots:
In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry
Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance
Jane highlights the benefits of NLP in ensuring regulatory…
Medical Affairs is a critical scientific bridge between Healthcare companies and their internal & external stakeholders. It plays a leadership role in implementing cutting-edge medical, scientific, and patient-centered insights & solutions that drive strategy and innovation in healthcare. The healthcare ecosystem is dynamic and being transformed with the latest tech solutions. It is believed that in…

